pmid,title,journal,year,drug,disease
40389963,Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases.,Virology journal,2025,Paxlovid,Chronic Liver Disease
38621119,Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.,Proceedings of the National Academy of Sciences of the United States of America,2024,Paxlovid,Chronic Liver Disease
38438015,The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.,Antiviral research,2024,Paxlovid,Chronic Liver Disease
37555275,A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.,Emerging microbes & infections,2023,Paxlovid,Chronic Liver Disease
37369283,Paxlovid for hospitalized COVID-19 patients with chronic kidney disease.,Antiviral research,2023,Paxlovid,Chronic Liver Disease
35899636,"[Prise en charge medicale du Covid-19, hors reanimation].",La Revue du praticien,2022,Paxlovid,Chronic Liver Disease
